Sampoerna announces a USD 330 million investment in a smoke-free product facility in Indonesia, highlighting its commitment to innovation and public health.

Information on the Target

PT HM Sampoerna Tbk. (Sampoerna), a leading tobacco company in Indonesia, has established a strong reputation for its innovative approaches toward tobacco and nicotine products. The company's initiatives emphasize science-based innovations to transform the tobacco industry, prioritizing the development of smoke-free products. Recently, Sampoerna has committed to investing USD 330 million in establishing a state-of-the-art manufacturing facility for smoke-free tobacco products in Karawang, West Java, which marks the company's first such production site in Southeast Asia and the seventh globally.

This new facility will feature a globally accredited Testing and Analysis Laboratory, becoming the only advanced lab of its kind in Asia, staffed by around 200 highly qualified local experts. This investment underscores Indonesia's role not only as a significant market but also as a global center for research and development in smoke-free tobacco products.

Industry Overview in Indonesia

Indonesia’s tobacco industry is characterized by a complex landscape filled with traditional and modern practices. Despite facing increasing scrutiny and regulatory challenges, the industry remains crucial for th